CONBA(SH:600572) Xin Lang Cai Jing·2025-10-29 04:03Core Insights - 康恩贝 reported a total operating revenue of 4.976 billion yuan for Q3 2025, ranking 7th among disclosed peers, with a year-on-year increase of 62.573 million yuan, representing a 1.27% growth compared to the same period last year [1] - The net profit attributable to shareholders reached 584 million yuan, ranking 9th among peers, with an increase of 65.577 million yuan, reflecting a year-on-year growth of 12.65% [1] - The net cash inflow from operating activities was 532 million yuan, ranking 9th among peers, with an increase of 73.0795 million yuan, showing a year-on-year growth of 15.94% [1] Financial Ratios - The latest debt-to-asset ratio is 29.33%, a decrease of 0.21 percentage points from the previous quarter and a decrease of 1.39 percentage points from the same period last year [3] - The latest gross profit margin is 53.78%, an increase of 0.06 percentage points from the previous quarter and an increase of 0.05 percentage points from the same period last year [3] - The latest return on equity (ROE) is 8.27%, ranking 13th among peers, with an increase of 0.48 percentage points from the same period last year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is 0.23 yuan, ranking 17th among peers, with an increase of 0.03 yuan, representing a year-on-year growth of 13.17% [3] - The latest total asset turnover ratio is 0.50 times, ranking 6th among peers, with an increase of 0.03 times from the same period last year, reflecting a year-on-year growth of 6.09% [3] - The latest inventory turnover ratio is 1.91 times, ranking 13th among peers, with an increase of 0.19 times, achieving five consecutive years of growth, and a year-on-year increase of 11.10% [3] Shareholder Structure - The number of shareholders is 86,700, with the top ten shareholders holding 1.139 billion shares, accounting for 45.12% of the total share capital [3] - The largest shareholder is 浙江省医药健康产业集团有限公司, holding 23.53% of the shares [3]